Structure |
Chemical Name |
CAS |
MF |
![(αR)-α-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-2-naphthalenemethanamine Hydrochloride](/CAS/20210111/GIF/2200269-28-7.gif) |
(αR)-α-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-2-naphthalenemethanamine Hydrochloride |
2200269-28-7 |
C22H23ClF3N |
![Hydroxyzine Acetic Acid Dihydrochloride](/CAS/GIF/83881-56-5.gif) |
Hydroxyzine Acetic Acid Dihydrochloride |
83881-56-5 |
C23H29ClN2O4 |
![Ceftazidime Double Mother Nucleus Impurity](/) |
Ceftazidime Double Mother Nucleus Impurity |
|
|
![(S)-ズロキセチンスクシンアミド](/CAS/GIF/199191-66-7.gif) |
(S)-ズロキセチンスクシンアミド |
199191-66-7 |
C22H23NO4S |
![Cefuroxime Sodium Trans Impurity I,(E)-Cefuroxime Sodium Impurity I](/) |
Cefuroxime Sodium Trans Impurity I,(E)-Cefuroxime Sodium Impurity I |
|
|
![4-Acetyl Rhein](/CAS/GIF/875535-36-7.gif) |
4-Acetyl Rhein |
875535-36-7 |
C17H10O7 |
![Faropenem Degradation Impurity B](/) |
Faropenem Degradation Impurity B |
|
|
![Ropivacaine N-Oxide](/CAS/20140608/GIF/CB42558372.gif) |
Ropivacaine N-Oxide |
1391053-59-0 |
C17H26N2O2 |
![2-chloro-1-(5-isopropoxy-5H-chromeno[2,3-b]pyridin-7-yl)propan-1-one](/) |
2-chloro-1-(5-isopropoxy-5H-chromeno[2,3-b]pyridin-7-yl)propan-1-one |
|
|
![Methyl 2-CarbaMoylbenzoate](/CAS/GIF/90564-02-6.gif) |
Methyl 2-CarbaMoylbenzoate |
90564-02-6 |
C9H9NO3 |
![Oxacillin Impurity 1](/CAS/20210305/GIF/36231-30-8.gif) |
Oxacillin Impurity 1 |
36231-30-8 |
C19H19N3O6S |
![カルバミン酸N-エチル-N-メチル-3-ビニルフェニル](/CAS/GIF/1346602-84-3.gif) |
カルバミン酸N-エチル-N-メチル-3-ビニルフェニル |
1346602-84-3 |
C12H15NO2 |
![Brivaracetam Impurity 33](/) |
Brivaracetam Impurity 33 |
|
|
![AMisulpride IMpurity D](/CAS/20150408/GIF/71676-00-1.gif) |
AMisulpride IMpurity D |
71676-00-1 |
C16H25N3O4S |
![AFuroseMide IMp. A (EP)](/) |
AFuroseMide IMp. A (EP) |
|
|
![Arformoterol Impurity 24](/CAS/20210111/GIF/477552-93-5.gif) |
Arformoterol Impurity 24 |
477552-93-5 |
C19H24N2O3 |
![(1R)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic acid ethyl ester](/CAS/GIF/180468-41-1.gif) |
(1R)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic acid ethyl ester |
180468-41-1 |
C18H19NO2 |
![Pregabalin Impurity 99](/CAS/20210111/GIF/949890-75-9.gif) |
Pregabalin Impurity 99 |
949890-75-9 |
C16H23NO4 |
![Roxatidine Impurity 9](/CAS/20210111/GIF/87327-60-4.gif) |
Roxatidine Impurity 9 |
87327-60-4 |
C4H6O4 |
![Regofenib impurity K](/) |
Regofenib impurity K |
|
|
![Chlorpheniramine Impurity 4](/) |
Chlorpheniramine Impurity 4 |
|
|
![Peramivir Impurity 43](/) |
Peramivir Impurity 43 |
|
|
![N-(4-BROMOBUTYL)-7-(4-BROMOBUTOXY)-QUINOLINE-2(1H)-ONE](/StructureFile/ChemBookStructure22/GIF/CB0648431.gif) |
N-(4-BROMOBUTYL)-7-(4-BROMOBUTOXY)-QUINOLINE-2(1H)-ONE |
1076199-56-8 |
C17H21Br2NO2 |
![METHYL 2-[(2,5-DICHLOROBENZOYL)AMINO]ACETATE](/StructureFile/ChemBookStructure4/GIF/CB0665441.gif) |
METHYL 2-[(2,5-DICHLOROBENZOYL)AMINO]ACETATE |
338965-44-9 |
C10H9Cl2NO3 |
![4-(ジフェニルメチル)-1-ピペラジンエタノール二塩酸塩](/CAS/GIF/108983-83-1.gif) |
4-(ジフェニルメチル)-1-ピペラジンエタノール二塩酸塩 |
108983-83-1 |
C19H26Cl2N2O |
![2-ピペラジニル-4-アミノ-6,7-ジメトキシキナゾリン](/CAS/GIF/60547-97-9.gif) |
2-ピペラジニル-4-アミノ-6,7-ジメトキシキナゾリン |
60547-97-9 |
C14H19N5O2 |
![N-アセチル-1,4-ベンゾキノンイミン](/CAS/GIF/50700-49-7.gif) |
N-アセチル-1,4-ベンゾキノンイミン |
50700-49-7 |
C8H7NO2 |
![ジゴキソシド](/CAS/GIF/31539-05-6.gif) |
ジゴキソシド |
31539-05-6 |
C47H74O17 |
![Sugammadex sodium Impurity 51](/) |
Sugammadex sodium Impurity 51 |
|
|
![Sugammadex sodium Impurity 42](/) |
Sugammadex sodium Impurity 42 |
|
|
![Org49095](/CAS/20211123/GIF/2412952-95-3.gif) |
Org49095 |
2412952-95-3 |
C71H111NaO48S8 |
![Clopidogrel Impurity 55](/) |
Clopidogrel Impurity 55 |
|
|
![Cabozantinib impurity 43](/) |
Cabozantinib impurity 43 |
|
|
![2-[4-[(RS)-(4-Chlorophenyl)phenylMethyl]-piperazin-1-yl]ethanolDihydrochloride](/CAS/20130318/GIF/CB42617044.gif) |
2-[4-[(RS)-(4-Chlorophenyl)phenylMethyl]-piperazin-1-yl]ethanolDihydrochloride |
|
C19H25Cl3N2O |
![CAPECITABINE related substance USP](/CAS/GIF/1262133-68-5.gif) |
CAPECITABINE related substance USP |
1262133-68-5 |
C20H30FN3O9 |
![4-AMino-N-[(1-ethyl-2-pyrrolidinyl)Methyl]-5-(ethylsulfonyl)- 2-MethoxybenzaMide N-Oxide](/CAS/GIF/71676-01-2.gif) |
4-AMino-N-[(1-ethyl-2-pyrrolidinyl)Methyl]-5-(ethylsulfonyl)- 2-MethoxybenzaMide N-Oxide |
71676-01-2 |
C17H27N3O5S |
![硫酸チアミン](/CAS/GIF/2380-61-2.gif) |
硫酸チアミン |
2380-61-2 |
C12H16N4O4S2 |
![1,4-Bis-[4-[4-Methyl-3-[[4-(pyridin-3-yl)pyriMidin-2-yl]aMino]phenyl]carbaMoyl]benzylpiperazine](/CAS/GIF/1365802-18-1.gif) |
1,4-Bis-[4-[4-Methyl-3-[[4-(pyridin-3-yl)pyriMidin-2-yl]aMino]phenyl]carbaMoyl]benzylpiperazine |
1365802-18-1 |
C52H48N12O2 |
![[6R-[6α,7β(R*)]]-7-[(AMinophenylacetyl)aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0](/CAS/20150408/GIF/79750-46-2.gif) |
[6R-[6α,7β(R*)]]-7-[(AMinophenylacetyl)aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0 |
79750-46-2 |
C16H17N3O4S |
![SalMeterol EP IMpurity D](/CAS/20130318/GIF/CB42622471.gif) |
SalMeterol EP IMpurity D |
1391052-04-2 |
C34H47NO7 |
![ニコチン酸2-アミノエチルエステル二塩酸塩](/CAS/GIF/87330-70-9.gif) |
ニコチン酸2-アミノエチルエステル二塩酸塩 |
87330-70-9 |
C8H11ClN2O2 |
![PeMetrexed EP IMpurity D](/CAS/20210111/GIF/144051-68-3.gif) |
PeMetrexed EP IMpurity D |
144051-68-3 |
C25H28N6O9 |
![SuMatriptan EP IMpurity F](/CAS/20150408/GIF/CB42630490.gif) |
SuMatriptan EP IMpurity F |
2074615-63-5 |
C13H17N3O2S |
![Perindopril Impurity](/) |
Perindopril Impurity |
|
|
![Ganciclovir Dipropionate](/CAS/20150408/GIF/86357-20-2.gif) |
Ganciclovir Dipropionate |
86357-20-2 |
C15H21N5O6 |
![Budesonide Impurity 20](/) |
Budesonide Impurity 20 |
|
|
![Glycine, N-[(4-methylphenyl)sulfonyl]glycyl-, ethyl ester](/CAS/20210111/GIF/2478-45-7.gif) |
Glycine, N-[(4-methylphenyl)sulfonyl]glycyl-, ethyl ester |
2478-45-7 |
C13H18N2O5S |
![Pneumocandin B0, 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-L-ornithine]-](/CAS/20211123/GIF/1404083-47-1.gif) |
Pneumocandin B0, 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-L-ornithine]- |
1404083-47-1 |
C52H86N10O16 |
![(E)-3-(4-((3-(1-(4-((1H-imidazol-1-yl)methyl)phenyl)-2-carboxyethyl)-1H-imidazol-3-ium-1-yl)methyl)phenyl)acrylate](/) |
(E)-3-(4-((3-(1-(4-((1H-imidazol-1-yl)methyl)phenyl)-2-carboxyethyl)-1H-imidazol-3-ium-1-yl)methyl)phenyl)acrylate |
|
|
![Cisatracurium besylate impurity 21](/) |
Cisatracurium besylate impurity 21 |
|
|
![Dacomitinib Impurity](/) |
Dacomitinib Impurity |
|
|
![2-(1-ベンジルピペリジン-4-イルメチル)-6-ヒドロキシ-5-メトキシインダン-1-オン](/CAS/GIF/120013-56-1.gif) |
2-(1-ベンジルピペリジン-4-イルメチル)-6-ヒドロキシ-5-メトキシインダン-1-オン |
120013-56-1 |
C23H27NO3 |
![2-(2-メチル-4-ニトロ-1-イミダゾリル)エタノール](/CAS/GIF/705-19-1.gif) |
2-(2-メチル-4-ニトロ-1-イミダゾリル)エタノール |
705-19-1 |
C6H9N3O3 |
![2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸ジメチル](/CAS/GIF/76258-20-3.gif) |
2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸ジメチル |
76258-20-3 |
C17H16N2O6 |
![3-(2-TRIFLUOROMETHYL-PHENYL)-PROPAN-1-OL](/CAS/GIF/191155-81-4.gif) |
3-(2-TRIFLUOROMETHYL-PHENYL)-PROPAN-1-OL |
191155-81-4 |
C10H11F3O |
![monocalcium mono((3R,5S,E)-7-(4-(2-fluorophenyl)-6-isopropyl-2- (N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6- enoate)](/) |
monocalcium mono((3R,5S,E)-7-(4-(2-fluorophenyl)-6-isopropyl-2- (N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6- enoate) |
|
|
![Benzenepropanoic acid, 4-(2-oxiranylmethoxy)-](/CAS/20210305/GIF/2167848-51-1.gif) |
Benzenepropanoic acid, 4-(2-oxiranylmethoxy)- |
2167848-51-1 |
C12H14O4 |
![ジメチル[(3S)-3-(1-ナフチルオキシ)-3-(2-チエニル)プロピル]アミン](/CAS/GIF/132335-46-7.gif) |
ジメチル[(3S)-3-(1-ナフチルオキシ)-3-(2-チエニル)プロピル]アミン |
132335-46-7 |
C19H21NOS |
![D-Tryptophan, N-(trifluoroacetyl)- (9CI)](/CAS/20210305/GIF/22220-03-7.gif) |
D-Tryptophan, N-(trifluoroacetyl)- (9CI) |
22220-03-7 |
C13H11F3N2O3 |
![2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-N-(5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-1H-indazol-3-yl)benzamide](/) |
2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-N-(5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-1H-indazol-3-yl)benzamide |
|
|
![1H-benzo[d][1,2,3]triazol-1-yl 2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoate](/) |
1H-benzo[d][1,2,3]triazol-1-yl 2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoate |
|
|
![1-エチル-3-(3-ジメチルアミノプロピル)尿素 HYDROCHLORIDE](/CAS/GIF/32897-26-0.gif) |
1-エチル-3-(3-ジメチルアミノプロピル)尿素 HYDROCHLORIDE |
32897-26-0 |
C8H19N3O |
![Brivaracetam Impurity 29](/) |
Brivaracetam Impurity 29 |
|
|
![L-erythro-Hexuronic acid, 3,5-dideoxy-, 1,1-dimethylethyl ester](/CAS/20211123/GIF/1501982-84-8.gif) |
L-erythro-Hexuronic acid, 3,5-dideoxy-, 1,1-dimethylethyl ester |
1501982-84-8 |
C10H18O5 |
![Benzoic acid, 2-(1',6'-dihydro-6'-oxo-1'-phenyl[2,3'-bipyridin]-5'-yl)-, methyl ester](/CAS/20210305/GIF/543699-60-1.gif) |
Benzoic acid, 2-(1',6'-dihydro-6'-oxo-1'-phenyl[2,3'-bipyridin]-5'-yl)-, methyl ester |
543699-60-1 |
C24H18N2O3 |
![1,1'-[1,2-エタンジイルビス(オキシ)]ビス[2-メトキシベンゼン]](/CAS/GIF/553-45-7.gif) |
1,1'-[1,2-エタンジイルビス(オキシ)]ビス[2-メトキシベンゼン] |
553-45-7 |
C16H18O4 |
![Dispiro[11H-benzo[5,6]cyclohepta[1,2-b]pyridine-11,2'-oxirane-3',4''-piperidine]-1''-carboxylic acid, 8-chloro-5,6-dihydro-, ethyl ester, 1-oxide](/CAS/20210305/GIF/1432057-93-6.gif) |
Dispiro[11H-benzo[5,6]cyclohepta[1,2-b]pyridine-11,2'-oxirane-3',4''-piperidine]-1''-carboxylic acid, 8-chloro-5,6-dihydro-, ethyl ester, 1-oxide |
1432057-93-6 |
C22H23ClN2O4 |
![Oseltamivir Impurity 109](/) |
Oseltamivir Impurity 109 |
|
|
![Oseltamivir Impurity 81](/) |
Oseltamivir Impurity 81 |
|
|
![Oseltamivir Impurity 71](/) |
Oseltamivir Impurity 71 |
|
|
![安息香酸(1R,2S,5R)-2-イソプロピル-5-メチルシクロヘキシル](/CAS/GIF/6284-35-1.gif) |
安息香酸(1R,2S,5R)-2-イソプロピル-5-メチルシクロヘキシル |
6284-35-1 |
C17H24O2 |
![1-ヒドラジノ-3-メチルチオ-2-プロパノール](/CAS/GIF/14359-97-8.gif) |
1-ヒドラジノ-3-メチルチオ-2-プロパノール |
14359-97-8 |
C4H12N2OS |
![Benzenemethanol, 4-(3-chloro-2-hydroxypropoxy)-](/CAS/20210305/GIF/293302-44-0.gif) |
Benzenemethanol, 4-(3-chloro-2-hydroxypropoxy)- |
293302-44-0 |
C10H13ClO3 |
![N,N-bis((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)pyridine-3-sulfonamide](/CAS/20240320/GIF/2514957-29-8.gif) |
N,N-bis((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)pyridine-3-sulfonamide |
2514957-29-8 |
C27H22F2N4O2S |
![2,4(1H,3H)-Pyrimidinedione, 1-β-L-ribofuranosyl-, 4-oxime (9CI)](/CAS/20211123/GIF/402725-23-9.gif) |
2,4(1H,3H)-Pyrimidinedione, 1-β-L-ribofuranosyl-, 4-oxime (9CI) |
402725-23-9 |
C9H13N3O6 |
![1H-Indole-2-sulfonic acid, 6-hydroxy-1-methyl-](/CAS/20210305/GIF/2271443-87-7.gif) |
1H-Indole-2-sulfonic acid, 6-hydroxy-1-methyl- |
2271443-87-7 |
C9H9NO4S |
![4-ヒドロキシ-2-オキソ-1-ピロリジン酢酸メチル](/CAS/GIF/85614-52-4.gif) |
4-ヒドロキシ-2-オキソ-1-ピロリジン酢酸メチル |
85614-52-4 |
C7H11NO4 |
![Sitagliptin EP Impurity 5](/) |
Sitagliptin EP Impurity 5 |
|
|
![Simvastatin Impurity 6](/) |
Simvastatin Impurity 6 |
|
|
![Pemetrexed Impurity 42](/) |
Pemetrexed Impurity 42 |
|
|
![6-アミノ-9H-プリン-9-エタノール](/CAS/GIF/707-99-3.gif) |
6-アミノ-9H-プリン-9-エタノール |
707-99-3 |
C7H9N5O |
![9-Azabicyclo[3.3.1]Nonane-9-Acetic Acid, 3-(Ethoxycarbonyl)-7-Oxo-, Ethyl Ester](/CAS/GIF/115956-03-1.gif) |
9-Azabicyclo[3.3.1]Nonane-9-Acetic Acid, 3-(Ethoxycarbonyl)-7-Oxo-, Ethyl Ester |
115956-03-1 |
C15H23NO5 |
![Cefathiamidine Impurity F](/) |
Cefathiamidine Impurity F |
|
|
![1-(Bromophenylmethyl)-4-chlorobenzene](/CAS/GIF/948-54-9.gif) |
1-(Bromophenylmethyl)-4-chlorobenzene |
948-54-9 |
C13H10BrCl |
![Dolutegravir Impurity 21](/) |
Dolutegravir Impurity 21 |
|
|
![O-Desethyl Candesartan Cilexetil](/CAS/GIF/869631-11-8.gif) |
O-Desethyl Candesartan Cilexetil |
869631-11-8 |
C31H30N6O6 |
![Epi Lovastatin](/CAS/GIF/79952-44-6.gif) |
Epi Lovastatin |
79952-44-6 |
C24H36O5 |
![Hydroxy Brimonidine](/CAS/GIF/1216379-05-3.gif) |
Hydroxy Brimonidine |
1216379-05-3 |
C11H12BrN5O |
![7-メトキシ-3,4-ジヒドロキノリン-2(1H)-オン](/CAS2/GIF/22246-17-9.gif) |
7-メトキシ-3,4-ジヒドロキノリン-2(1H)-オン |
22246-17-9 |
C10H11NO2 |
![N-ベンジル-1-(4-メトキシフェニル)プロパン-2-アミン塩酸塩](/CAS2/GIF/1049695-95-5.gif) |
N-ベンジル-1-(4-メトキシフェニル)プロパン-2-アミン塩酸塩 |
1049695-95-5 |
C17H21NO.HCl |
![モンテルカストメチルケトン](/CAS/GIF/937275-23-5.gif) |
モンテルカストメチルケトン |
937275-23-5 |
C34H32ClNO3S |
![Propyl Itraconazole](/CAS/GIF/74855-91-7.gif) |
Propyl Itraconazole |
74855-91-7 |
C34H36Cl2N8O4 |
![3-methyleneisobenzofuran-1(3H)-one](/CAS2/GIF/3453-63-2.gif) |
3-methyleneisobenzofuran-1(3H)-one |
3453-63-2 |
C9H6O2 |
![Irbesartan impurity A](/CAS/20200331/GIF/CB62514437.gif) |
Irbesartan impurity A |
|
C25H28N6O |
![(N-tert-Butoxycarbonyl-N-[(1'R)-hydroxy-1-phenyl)ethyl])-4-nitrophenylethylaMine](/CAS/20180713/GIF/223673-35-6.gif) |
(N-tert-Butoxycarbonyl-N-[(1'R)-hydroxy-1-phenyl)ethyl])-4-nitrophenylethylaMine |
223673-35-6 |
C21H26N2O5 |
![Azelastine N-Oxide](/CAS/GIF/640279-88-5.gif) |
Azelastine N-Oxide |
640279-88-5 |
C22H24ClN3O2 |
![4-(8-クロロ-6,11-ジヒドロ-5H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン-11-イル)-3-ピリジノール1-オキシド](/CAS/GIF/1193725-75-5.gif) |
4-(8-クロロ-6,11-ジヒドロ-5H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン-11-イル)-3-ピリジノール1-オキシド |
1193725-75-5 |
C19H15ClN2O2 |
![16α,17,21-Trihydroxy-pregna-1,4-diene-3,11,20-trione](/CAS/GIF/3754-05-0.gif) |
16α,17,21-Trihydroxy-pregna-1,4-diene-3,11,20-trione |
3754-05-0 |
C21H26O6 |
![4H-Furo[2,3-c]pyranyl Mupirocin SodiuM IMpurity](/CAS/GIF/116182-43-5.gif) |
4H-Furo[2,3-c]pyranyl Mupirocin SodiuM IMpurity |
116182-43-5 |
C26H43NaO9 |
![N-(3-エチニル-4-メチルフェニル)-6,7-ビス(2-メトキシエトキシ)キナゾリン-4-アミン](/CAS/20140608/GIF/CB62544810.gif) |
N-(3-エチニル-4-メチルフェニル)-6,7-ビス(2-メトキシエトキシ)キナゾリン-4-アミン |
1346601-52-2 |
C23H25N3O4 |